AU2020902218A0 - New treatment for neurodegenerative diseases - Google Patents

New treatment for neurodegenerative diseases

Info

Publication number
AU2020902218A0
AU2020902218A0 AU2020902218A AU2020902218A AU2020902218A0 AU 2020902218 A0 AU2020902218 A0 AU 2020902218A0 AU 2020902218 A AU2020902218 A AU 2020902218A AU 2020902218 A AU2020902218 A AU 2020902218A AU 2020902218 A0 AU2020902218 A0 AU 2020902218A0
Authority
AU
Australia
Prior art keywords
neurodegenerative diseases
new treatment
treatment
new
neurodegenerative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU2020902218A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genieus Genomics Pty Ltd
Original Assignee
Genieus Genomics Pty Ltd
Filing date
Publication date
Application filed by Genieus Genomics Pty Ltd filed Critical Genieus Genomics Pty Ltd
Publication of AU2020902218A0 publication Critical patent/AU2020902218A0/en
Withdrawn legal-status Critical Current

Links

AU2020902218A 2020-06-30 New treatment for neurodegenerative diseases Withdrawn AU2020902218A0 (en)

Publications (1)

Publication Number Publication Date
AU2020902218A0 true AU2020902218A0 (en) 2020-07-16

Family

ID=

Similar Documents

Publication Publication Date Title
EP3986392A4 (en) Compounds for treatment of pd-l1 diseases
EP3890725A4 (en) Compositions for treating dermatological diseases
EP3773629A4 (en) Car-treg-based therapies for treating neurodegenerative diseases
EP3697401A4 (en) Dominant negative sarm1 molecules as a therapeutic strategy for neurodegenerative diseases or disorders
EP3856243A4 (en) Methods of treating neurodegenerative diseases
EP3934646A4 (en) Pharmaceutical compositions for treating ocular diseases or disorders
EP3685840A4 (en) Compound pharmaceutical composition for treating inflammatory skin diseases
EP4017490A4 (en) Compounds and methods for treating oxalate-related diseases
EP3954368A4 (en) Compound for treating neurodegenerative disorders
EP3936124A4 (en) Pharmaceutical composition for preventing or treating neurological diseases
EP3862012A4 (en) Therapeutic agent for neurodegenerative disease
EP3761982A4 (en) Treatment of demyelinating diseases
EP3534954A4 (en) Compounds for treatment of neurodegenerative diseases
EP3909568A4 (en) Prophylactic or therapeutic drug for neurodegenerative diseases
AU2021901964A0 (en) New treatment for neurodegenerative diseases
AU2020902218A0 (en) New treatment for neurodegenerative diseases
EP3846816A4 (en) Neuroprotective agents for treatment of neurodegenerative diseases
EP4010326A4 (en) Kinase inhibitors for the treatment of neurodegenerative diseases
AU2022901811A0 (en) New treatment for neurodegenerative diseases
EP4065712A4 (en) Gene therapy for neurodegenerative disorders
EP3946414A4 (en) Method for treating ocular diseases
EP3866779A4 (en) Treatment of neurological diseases
EP3761981A4 (en) Treatment of demyelinating diseases
EP3946266A4 (en) Sumo peptides for treating neurodegenerative diseases
EP3935057A4 (en) Compounds for treating neurodegenerative diseases and cancers